Pharmaceuticals
Healthcare
Ranbaxy sues US drug regulator over revoking approvals
Daiichi Sankyo-controlled Ranbaxy Laboratories has sued the US Food & Drug Administration (FDA) for revoking approvals granted to it to ......
Healthcare
Sami Labs eyes two more acquisitions in a year
Bangalore-based Sami Labs Ltd that manufactures and markets phytonutrients and standardised herbal extracts, specialty fine chemicals and organic intermediates used ......
Healthcare
Cadila looks to set up $16M fund to back pharma startups
Ahmedabad-based Cadila Pharmaceuticals Ltd is planning to set up a fund with a corpus of Rs 50-100 crore (up to ......
Healthcare
Jubilant Life Sciences seeks to complete buyout of US-based Cadista for up to $33.2M
Jubilant Pharma Limited (JPL), a Singapore-based wholly-owned subsidiary of Jubilant Life Sciences Limited, has commenced a tender offer to acquire ......
Healthcare
Aurobindo emerges top bidder to buy nutritional supplements maker Natrol for $132.5M
Hyderabad-based Aurobindo Pharma Ltd has emerged as the highest bidder for acquisition of American nutritional supplement maker, Natrol Inc and ......
Healthcare
Sami Labs acquires biotech arm of KCP
Bangalore-based Sami Labs Ltd has acquired the biotech arm of KCP, a Chennai-based 73 year old business group with interests ......
Healthcare
Johnson & Johnson acquires Jagdale's electrolyte drink brand ORSL
Global healthcare products major Johnson & Johnson (J&J) has acquired the ORSL ready-to-drink electrolyte brand from Jagdale Healthcare, as per ......
Healthcare
Novartis India divesting animal health unit to Eli Lilly for $14M
Novartis India Ltd, a subsidiary of Germany-based Novartis AG, has approved sale of its animal health business to Elanco India ......
Healthcare
USFDA revokes Ranbaxy's approval to sell generic versions of Nexium and Valcyte
The American drug regulator has revoked Ranbaxy Laboratories' tentative approval for selling copycat low-cost versions of blockbuster heartburn drug Nexium ......
Healthcare
Glenmark Pharmaceuticals may raise up to $300M
Mumbai-based Glenmark Pharmaceuticals Limited, which focuses on research to develop new chemical entities (NCEs) and new biological entities (NBEs), is ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News